Atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive adenocarcinoma, invasive adenocarcinoma
Conditions
Interventions
immediate surgery group:None
stable group (delayed surgery group):None
growth group (delayed surgery group):None
Sponsors
Fifth Affiliated Hospital, Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Visited Sun Yat-sen University Fifth Affiliated Hospital from 2017 to 2022; 3. Had pulmonary nodules; 4. Underwent surgical treatment and the pathological diagnosis was atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma (IAC) of the pulmonary nodules; 5. Had at least one CT examination before the surgery; 6. Did not receive neoadjuvant therapy before the surgery.
Exclusion criteria
Exclusion criteria: 1. Preoperative CT images were missing; 2. Preoperative CT images with slice thickness exceeding 1.25mm; 3. Baseline CT showed solid nodules and part-solid nodules.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival;recurrence-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| independent risk factor; | — |
Countries
China
Contacts
Public ContactYaqin Zhang
Fifth Affiliated Hospital, Sun Yat-Sen University
Outcome results
None listed